Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05785182 · ClinicalTrials.gov registry record

OCT in Open Fracture and Infected Fracture

A clinical trial of Trauma and Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT05785182 is a study of Trauma and Trauma Injury that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 40 participants, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05785182, a study of Trauma and Trauma Injury, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This is a pilot prospective, observational study of patients with open or infected fracture evaluating the feasibility and acceptability of OCT, a light-based imaging modality that requires no drug or contrast agent.

Interventions

  • PROCEDURE Open Fracture
  • PROCEDURE Infected Fracture

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-03-27
Est. Completion 2027-06

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT05785182

The ClinicalTrials.gov registry entry for NCT05785182 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (87% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Open Fracture is the first listed.

NCT05785182 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05785182 about?

NCT05785182 is a clinical study titled "OCT in Open Fracture and Infected Fracture". This is a pilot prospective, observational study of patients with open or infected fracture evaluating the feasibility and acceptability of OCT, a light-based imaging modality that requires no drug or contrast agent.

What is the current status of trial NCT05785182?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-03-27. Estimated completion is 2027-06.

What conditions does trial NCT05785182 study?

This clinical trial studies the following conditions: Trauma, Trauma Injury, Open Fracture, Fracture Infection.

What interventions are being tested in trial NCT05785182?

The interventions under investigation include: Open Fracture (PROCEDURE), Infected Fracture (PROCEDURE).

Who is sponsoring clinical trial NCT05785182?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05785182 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.